Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06515535
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During Elective Cesarean Delivery in Patients With Placenta Previa
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objectives To evaluate the efficacy of topical tranexamic acid applied on the placental bed after placental delivery to reduce blood loss during cesarean delivery in women with placenta previa
Patients will be randomly assigned into two groups
Group A - Study group n28 The topical tranexamic acid group will receive topical tranexamic acid after placental delivery applied on the placental bed for 5 minutes by using a sterile towel soaked with 2g tranexamic acid Kapron Amoun Cairo Egypt 4 ampules 500ug diluted in 100ml of sodium chloride 09 in addition to the IV infusion of 1g tranexamic acid 2 ampules 500ug diluted with 20ml of 5 glucose administered just after delivery of the fetus
Group B - Control group n28 The intravenous tranexamic acid group will receive only an IV infusion of 1g of tranexamic acid 2 ampules 500ug diluted with 20 ml of 5 glucose administered just after delivery of the fetus
Patients will be randomly assigned into two groups
Group A - Study group n28 The topical tranexamic acid group will receive topical tranexamic acid after placental delivery applied on the placental bed for 5 minutes by using a sterile towel soaked with 2g tranexamic acid Kapron Amoun Cairo Egypt 4 ampules 500ug diluted in 100ml of sodium chloride 09 in addition to the IV infusion of 1g tranexamic acid 2 ampules 500ug diluted with 20ml of 5 glucose administered just after delivery of the fetus
Group B - Control group n28 The intravenous tranexamic acid group will receive only an IV infusion of 1g of tranexamic acid 2 ampules 500ug diluted with 20 ml of 5 glucose administered just after delivery of the fetus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None